logo
Plus   Neg
Share
Email

EARNINGS SUMMARY: Details of Rigel Pharmaceuticals Inc. Q4 Earnings Report

Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL):

-Earnings: -$19.24 million in Q4 vs. -$17.20 million in the same period last year.
-EPS: -$0.11 in Q4 vs. -$0.10 in the same period last year.
-Analysts projected -$0.11 per share
-Revenue: $18.45 million in Q4 vs. $15.40 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT